Literature DB >> 12417106

Measurement of glial fibrillary acidic protein in blood: an analytical method.

Wieneke J A van Geel1, Herman P M de Reus, Henk Nijzing, Marcel M Verbeek, Pieter E Vos, Karel J B Lamers.   

Abstract

BACKGROUND: In the present study, a new assay for the measurement of glial fibrillary acidic protein (GFAP) in human blood is described. The aim of the study was to present the characteristics of a new GFAP assay for blood analysis.
METHODS: The method, a newly developed enzyme-linked immunosorbent assay (ELISA), was validated using blood samples from healthy blood donors and from patients with severe traumatic brain injury (TBI).
RESULTS: 22 out of 72 healthy blood donors had a detectable GFAP level. The reference values (percentiles) are as follows: P50=0.15 microg/l and P95=0.49 microg/l; range 0.15-0.76 microg/l.
CONCLUSIONS: GFAP in blood might be a promising new marker for astrocyte involvement after acute brain damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417106     DOI: 10.1016/s0009-8981(02)00330-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 2.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

Review 3.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

4.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

5.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Authors:  Linda Papa; Salvatore Silvestri; Gretchen M Brophy; Philip Giordano; Jay L Falk; Carolina F Braga; Ciara N Tan; Neema J Ameli; Jason A Demery; Neha K Dixit; Matthew E Mendes; Ronald L Hayes; Kevin K W Wang; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2014-09-12       Impact factor: 5.269

6.  GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.

Authors:  David O Okonkwo; John K Yue; Ava M Puccio; David M Panczykowski; Tomoo Inoue; Paul J McMahon; Marco D Sorani; Esther L Yuh; Hester F Lingsma; Andrew I R Maas; Alex B Valadka; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2013-08-01       Impact factor: 5.269

7.  Using the olfactory system as an in vivo model to study traumatic brain injury and repair.

Authors:  Elizabeth Steuer; Michele L Schaefer; Leonardo Belluscio
Journal:  J Neurotrauma       Date:  2014-06-17       Impact factor: 5.269

8.  The role of markers of inflammation in traumatic brain injury.

Authors:  Thomas Woodcock; Maria Cristina Morganti-Kossmann
Journal:  Front Neurol       Date:  2013-03-04       Impact factor: 4.003

Review 9.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

10.  Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.

Authors:  J Susie Zoltewicz; Dancia Scharf; Boxuan Yang; Aarti Chawla; Kimberly J Newsom; Lijuan Fang
Journal:  Biomark Insights       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.